Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

CompletedOBSERVATIONAL
Enrollment

889

Participants

Timeline

Start Date

July 31, 2009

Study Completion Date

December 31, 2009

Conditions
Gastroesophageal Reflux Disease
Trial Locations (54)

Unknown

Research Site, Pátrai

Research Site, Mesologgion

Research Site, Naupaktos

Research Site, Grinion

Research Site, Aleksandroupoli

Research Site, Tripoli

Research Site, Acharnes

Research Site, Ag.Eleutherios

Research Site, Ag.Paraskeui

Research Site, Artémida

Research Site, Athens

Research Site, Chalandri

Research Site, Galatsi

Research Site, Glifada

Research Site, Ilipoli

Research Site, Kallithea

Research Site, Keratea

Research Site, Marousi

Research Site, N Makri

Research Site, N Smirni

Research Site, N.Herakeleios

Research Site, Peristeri

Research Site, Pikermi

Research Site, Pikerni

Research Site, Spata

Research Site, Chalcis

Research Site, Chalkidiki

Research Site, Chania

Research Site, Corinth

Research Site, Mykonos

Research Site, Santorini

Research Site, Drama

Research Site, Zakynthos

Research Site, Lamia

Research Site, Heraklion

Research Site, Lexena

Research Site, Véroia

Research Site, Ioannina

Research Site, Karditsa

Research Site, Kastoria

Research Site, Katerini

Research Site, Chrisoupoli

Research Site, Komotini

Research Site, Lakonia

Research Site, Larrisa

Research Site, Volos

Research Site, Kalamata

Research Site, Giannitsá

Research Site, Pereus

Research Site, Ptolemaida

Research Site, Thessaloniki

Research Site, Serres

Research Site, Trikala

Research Site, Xánthi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY